# Heart Failure IDentification in a High Risk Cardiovascular OutpatiEnt Population (HIDE)

> **NCT04143919** · NA · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 317 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DIAGNOSTIC_TEST:** NYHA assessment
- **PROCEDURE:** Serum NT-proBNP concentration
- **DIAGNOSTIC_TEST:** Transthoracic Ecocardiogram

## Key facts

- **NCT ID:** NCT04143919
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-31
- **Primary completion:** 2021-06-07
- **Final completion:** 2021-06-11
- **Target enrollment:** 317 (ACTUAL)
- **Last updated:** 2022-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04143919

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04143919, "Heart Failure IDentification in a High Risk Cardiovascular OutpatiEnt Population (HIDE)". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT04143919. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*